William Hoi Hong Li
South College(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Autophagy in Disease and Therapy, Endoplasmic Reticulum Stress and Disease, Ubiquitin and proteasome pathways, Quinazolinone synthesis and applications, Cyclization and Aryne Chemistry
Most-Cited Works
- → Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)(2012)608 cited
- → Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development(2013)226 cited
- → Concerted vs Stepwise Mechanisms in Dehydro-Diels–Alder Reactions(2011)101 cited
- → An efficient and practical synthesis of 2,4-substituted pyrido[4,3-d]pyrimidin-5(6H)-ones(2019)2 cited